{"nctId":"NCT01260883","briefTitle":"Ketorolac in Postoperative Infants: Pharmacokinetics and Safety","startDateStruct":{"date":"2000-05"},"conditions":["Postoperative Pain in Infants"],"count":77,"armGroups":[{"label":"ketorolac 1 mg/kg","type":"EXPERIMENTAL","interventionNames":["Drug: Ketorolac Tromethamine 1 mg/kg"]},{"label":"ketorolac 0.5 mg/kg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Ketorolac Tromethamine 0.5 mg/kg"]},{"label":"placebo","type":"SHAM_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Ketorolac Tromethamine 1 mg/kg","otherNames":["toradol"]},{"name":"Ketorolac Tromethamine 0.5 mg/kg","otherNames":["toradol"]},{"name":"Placebo","otherNames":["Dextrose in water (D5W)"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Non-prematurely-born infants admitted to hospital following surgery ages 2-18 months, studied by age group 12-18 months, 6-12 months, \\< 6 months\n\nExclusion Criteria:\n\n* Bleeding history in infant or family\n* Coagulopathy\n* Gastrointestinal bleeding history\n* Renal or hepatic disease assessed by history and by pre-drug blood tests\n* Premature birth (\\<36 weeks gestation)","healthyVolunteers":false,"sex":"ALL","minimumAge":"2 Months","maximumAge":"18 Months","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clearance of S-ketorolac and R+ Ketorolac in 2-6 Month Old Infants Following Surgery","description":"stereo-isomer specific clearance determined by population-based pharmacokinetic analysis (NONMEM)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30.7","spread":"22.8"},{"groupId":"OG001","value":"6.5","spread":"2.2"}]}]}]},{"type":"PRIMARY","title":"Central Volume of Distribution for S- and R+ Ketorolac in 2-6 Month Old Infants","description":"stereo-specific ketorolac analysis using population-based analysis (NONMEM)for ketorolac given intravenously 24 hours after surgery in 2-6 month old infants","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1480","spread":"920"},{"groupId":"OG001","value":"992","spread":"440"}]}]}]},{"type":"PRIMARY","title":"Peripheral Volume of Distribution for S- and R+ Ketorolac in 2-6 Month Old Infants","description":"peripheral volume of distribution for ketorolac stereo-isomers determined by population kinetic analysis (NONMEM)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"341","spread":"342"},{"groupId":"OG001","value":"658","spread":"207"}]}]}]},{"type":"PRIMARY","title":"Half-life of S- and R+ Ketorolac in 2-6 Month Old Infants","description":"half-life calculated from non-compartmental analysis of ketorolac isomers in 2-6 month old infants given intravenous ketorolac following surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67","spread":"33"},{"groupId":"OG001","value":"197","spread":"82"}]}]}]},{"type":"SECONDARY","title":"Morphine Use in 2-6 Month Old Infants Given Ketorolac or Placebo Following Surgery","description":"total morphine given intravenously in the 12 hours following receiving intravenous ketorolac or placebo","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"0.28"},{"groupId":"OG001","value":"0.08","spread":"0.12"}]}]}]},{"type":"SECONDARY","title":"Percent Time With Room Air Oximetry Saturations Under 90% in 2-6 Month Infants","description":"continuous oximetry monitoring of room air saturation was collected for 12 hours after intravenous infusion of ketorolac or placebo","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null}]}]}]},{"type":"PRIMARY","title":"Clearance of S- and R+ Ketorolac in 6-18 Month Old Infants","description":"stereo-specific ketorolac clearance by population-based analysis (NONMEM)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45.3","spread":"12.1"},{"groupId":"OG001","value":"7.52","spread":"9.3"}]}]}]},{"type":"PRIMARY","title":"Volume of Distribution for Ketorolac Isomers in 6-18 Month Old Infants","description":"population-based kinetic analysis of ketorolac isomers following intravenous infusion in infants after surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2320","spread":"14.6"},{"groupId":"OG001","value":"1200","spread":"13.6"}]}]}]},{"type":"PRIMARY","title":"Ketorolac Stereo-isomer Volume of Distribution Peripheral in 6-18 Month Old Infants","description":"population-based analysis of ketorolac stereo-isomers","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"224","spread":"86"},{"groupId":"OG001","value":"828","spread":"13"}]}]}]},{"type":"PRIMARY","title":"Half-life of Ketorolac Stereo-isomers in 6-18 Month Old Infants After Surgery","description":"noncompartmental pharmacokinetic analysis of ketorolac stereo-isomers after intravenous infusion in postoperative infants","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50.1","spread":"42"},{"groupId":"OG001","value":"238","spread":"48"}]}]}]},{"type":"SECONDARY","title":"Total Morphine Use in 6-18 Month Old Infants After Ketorolac or Placebo Intravenous Infusion After Surgery","description":"total amount of morphine given for 12 hours after ketorolac or placebo infusion in 6-18 month old infants after surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"1.5"},{"groupId":"OG001","value":"2.2","spread":"1.4"}]}]}]},{"type":"SECONDARY","title":"Oximetry Saturation Under 90% After Ketorolac or Placebo Infusion in 6-18 Month Old Infants","description":"continuous oximetry monitoring for 12 hours after ketorolac or placebo intravenous infusion in 6-18 month old infants after surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"0.8"},{"groupId":"OG001","value":"1","spread":"1"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":22},"commonTop":[]}}}